Osteosarcoma in preadolescent patients

Clinical Orthopaedics and Related Research

Volumn 373, Issue , 2000, Pages 39-50

  Rytting, Michael ^a   Pearson, Peggy ^a   Raymond, A Kevin ^a   Ayala, Alberto ^a   Murray, John ^a   Yasko, Alan W ^a   Johnson, Mark ^a   Jaffe, Norman ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BONE CANCER; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HISTOLOGY; HUMAN; MALE; OSTEOSARCOMA; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034002174     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200004000-00007     Document Type: Conference Paper

References (30)

1. Ayala AG, Mackay B, Jaffe N, et al: The Pathological Study of Specimens From En Bloc Resection in Patients Receiving Pre-Operative Chemotherapy. In van Eys J, Sullivan MP (eds). Status of Curability of Childhood Cancers. New York, Raven 127-144, 1980.
2. Bacci G, Picci P, Ferrari S, et al: Prognostic significance of serum alkaline phosphatase mesurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer 71:1224-1230, 1993.
3. Bentzen SM, Poulsen HS, Kaae S, et al: Prognostic factors in osteosarcoma: A regression analysis. Cancer 62:194-202, 1988.
4. Benjamin RS, Chawla C, Carrasco C, et al: Arterial Infusion in the Treatment of Osteosarcoma. In Ryan JR, Baker LO (eds). Recent Concepts in Sarcoma Treatment. Boston, MA, Kluwer Academic 269-274, 1988.
5. Bieling P, Rehan N, Winkler P, et al: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 14:848-858, 1996.
6. Dahlin DC, Unni KK: Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol 1:61-72, 1977.
7. Dorfman HD, Czerniak B: Bone cancers. Cancer 75(1 Suppl):203-210, 1995.
8. Gurney J, Seerson R, Davis S, et al: Incidence of cancer in children in the United States. Cancer 75:2186-2195, 1995.
9. Herson J, Sutow W, Elder K, et al: Adjuvant chemotherapy in nonmetastatic osteosarcoma: A Southwest Oncology Group Study. Med Pediatr Oncol 8: 343-352, 1980.
10. Hudson M, Jaffe MR, Jaffe N, et al: Pediatric osteosarcoma: Strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol 8: 1988-1997, 1990.
11. Jaffe N, Wallace, Carrasco HC, et al: Pediatric osteosarcoma: Can cure be achieved with chemotherapy (only) and elimination of surgery? Proc Am Soc Clin Oncol 12:420, 1993. Abstract.
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-281, 1958.
13. Kozakewich H, Perez-Atayde A, Goorin A, et al: Osteosarcoma in young children. Cancer 67:638-642, 1990.
14. Krailo M, Ertel I, Makley J, et al: A randomized study comparing high dose methotreate with moderate dose methotrexate as compenents of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: A report from the Children's Cancer Study Group. Med Pediatr Oncol 15:669-677, 1987.
15. Levine A, Rosenberg S: Alkaline phosphatase levels in osteosarcoma tissue are related to prognosis. Cancer 44:2291-2293, 1979.
16. Link M, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. New Engl J Med 314:1600-1606, 1986.
17. Lockshin M, Higgins I: Prognosis in osteogenic sarcoma. Clin Orthop 58:85-101, 1968.
18. McKenna RI, Schwinn CP, Soong KY, Higinbotham NL: Sarcomata of the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal osteogenic sarcoma and sarcomata arising in abnormal bone). An analysis of 552 cases. J Bone Joint Surg 48A:1-26, 1966.
19. Novakovic B: United States childhood cancer survival, 1973-1987. Med Pediatr Oncol 23:480-486, 1995.
20. Petrilli A, Gentil F, Epelman S, et al: Increased survival, limb preservation and prognostic factors for osteosarcoma. Cancer 68: 733-737, 1991.
21. Picci P, Sangiorgi L, Rougraff B, et al: Relationship of chemotherapy induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699-2705, 1994.
22. Provisor A, Ettinger L, Nachman J, et al: Treatment of nonmetastatic osteosarcoma of the extremity with pre- and postoperative chemotherapy, CCG-782. A report from the Children's Cancer Group. J Clin Oncol 15:76-84, 1997
23. Raymond AK, Chawla SP, Carrasco CH, et al: Osteosarcoma chemotherapy effect: A prognostic factor. Semin Diagnostic Pathol 4:212-236, 1987.
24. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteosarcoma. Selection of post-operative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230, 1982.
25. Scranton P, DeCiccio F, Totten R, et al: Prognostic factors in osteosarcoma: a review of 20 years at the University of Pittsburg Health Center hospitals. Cancer 36:2179-2191, 1975.
26. Stark A, Kreicbergs A, Nisoone U, et al: The age of osteosarcoma patients is increasing. J Bone Joint Surg 72B: 89-93, 1990.
27. Tanner JM: Growth at Adolescence. Ed 2. Oxford, England, Blackwell Scientific Publications 1962.
28. Taylor WF, Ivins JC, Unni KK, et al: Prognostic variables in osteosarcoma: A multi-institutional study. J Natl Cancer Inst 81:21-30, 1989.
29. Thorpe W, Reilly J, Rosenberg S: Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy. Cancer 43:2170-2181, 1979.
30. Winkler K, Beron G, Kotz R, et al: Neoadjuvant chemotherapy for osteosarcoma: Results of a cooperative German/Austrian study. J Clin Oncol 2:617-624, 1984.